BiotechTube
Home/Fimbrion Therapeutics/Christina L. Stallings
CL

Christina L. Stallings

Board Member

Fimbrion Therapeutics

Therapeutic Areas

Infectious DiseaseUrinary Tract InfectionsTuberculosis

Fimbrion Therapeutics Pipeline

DrugIndicationPhase
UTI Program (with GSK)Treatment & Prevention of Recurrent Urinary Tract InfectionsPhase 1
Tuberculosis ProgramTuberculosisPreclinical

Leadership Team at Fimbrion Therapeutics

TJ
Thomas J. Hannan
Chief Scientific Officer
SJ
Scott J. Hultgren
Co-Founder, Board Member
JW
James W. Janetka
Co-Founder, Board Member
TM
Thomas M. Hooton
Co-Founder, Board Member
View full Fimbrion Therapeutics profile